These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 7503758)
41. Correlation between pulmonary cytochrome P450 transcripts and the organ-selective pneumotoxicity of 3-methylindole. Ramakanth S; Thornton-Manning JR; Wang H; Maxwell H; Yost GS Toxicol Lett; 1994 Mar; 71(1):77-85. PubMed ID: 8140592 [TBL] [Abstract][Full Text] [Related]
42. Baculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2a6: role in metabolic activation of nasal toxicants. Liu C; Zhuo X; Gonzalez FJ; Ding X Mol Pharmacol; 1996 Oct; 50(4):781-8. PubMed ID: 8863822 [TBL] [Abstract][Full Text] [Related]
43. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Su T; Bao Z; Zhang QY; Smith TJ; Hong JY; Ding X Cancer Res; 2000 Sep; 60(18):5074-9. PubMed ID: 11016631 [TBL] [Abstract][Full Text] [Related]
44. Reversal of cytochrome P-4501A1 and P-450-EF expression in MCA-C3H/10T1/2 cell-derived tumors as compared to cultured cells. Christou M; Keith IM; Shen X; Schroeder ME; Jefcoate CR Cancer Res; 1993 Mar; 53(5):968-76. PubMed ID: 8439972 [TBL] [Abstract][Full Text] [Related]
45. Elevated susceptibility to 4-ipomeanol cytotoxicity in immature Clara cells of neonatal rabbits. Plopper CG; Weir AJ; Nishio SJ; Chang A; Voit M; Philpot RM; Buckpitt AR J Pharmacol Exp Ther; 1994 May; 269(2):867-80. PubMed ID: 8182556 [TBL] [Abstract][Full Text] [Related]
46. Spotlight on CYP4B1. Röder A; Hüsken S; Hutter MC; Rettie AE; Hanenberg H; Wiek C; Girhard M Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768362 [TBL] [Abstract][Full Text] [Related]
47. Pulmonary cytochrome P450 enzymes belonging to the CYP4B subfamily from an Australian marsupial, the tammar wallaby (Macropus eugenii). Milic NL; Ngo SN; Marchant CL; Height TA; McKinnon RA Comp Biochem Physiol C Toxicol Pharmacol; 2011 Jan; 153(1):60-6. PubMed ID: 20826229 [TBL] [Abstract][Full Text] [Related]
48. Optimized human CYP4B1 in combination with the alkylator prodrug 4-ipomeanol serves as a novel suicide gene system for adoptive T-cell therapies. Roellecke K; Virts EL; Einholz R; Edson KZ; Altvater B; Rossig C; von Laer D; Scheckenbach K; Wagenmann M; Reinhardt D; Kramm CM; Rettie AE; Wiek C; Hanenberg H Gene Ther; 2016 Jul; 23(7):615-26. PubMed ID: 27092941 [TBL] [Abstract][Full Text] [Related]
49. A transgenic mouse expressing human CYP4B1 in the liver. Imaoka S; Hayashi K; Hiroi T; Yabusaki Y; Kamataki T; Funae Y Biochem Biophys Res Commun; 2001 Jun; 284(3):757-62. PubMed ID: 11396967 [TBL] [Abstract][Full Text] [Related]
50. Mechanism-based inactivation of cytochrome P450 3A4 by 4-ipomeanol. Alvarez-Diez TM; Zheng J Chem Res Toxicol; 2004 Feb; 17(2):150-7. PubMed ID: 14967002 [TBL] [Abstract][Full Text] [Related]
52. Renal toxicity due to reactive metabolites formed in situ in the kidney: investigations with 4-ipomeanol in the mouse. Boyd MR; Dutcher JS J Pharmacol Exp Ther; 1981 Mar; 216(3):640-6. PubMed ID: 7205642 [TBL] [Abstract][Full Text] [Related]
53. Function and localization of cytochromes P450 involved in the metabolic activation of food-derived heterocyclic amines. McKinnon RA; McManus ME Princess Takamatsu Symp; 1995; 23():145-53. PubMed ID: 8844805 [TBL] [Abstract][Full Text] [Related]
54. Influence of benzoflavone on aflatoxin B1-induced cytotoxicity, mutation, and transformation of C3H/10T1/2 cells. Billings PC; Uwaifo AO; Heidelberger C Cancer Res; 1983 Jun; 43(6):2659-63. PubMed ID: 6406051 [TBL] [Abstract][Full Text] [Related]
55. Study of the ability of phenacetin, acetaminophen, and aspirin to induce cytotoxicity, mutation, and morphological transformation in C3H/10T1/2 clone 8 mouse embryo cells. Patierno SR; Lehman NL; Henderson BE; Landolph JR Cancer Res; 1989 Feb; 49(4):1038-44. PubMed ID: 2912548 [TBL] [Abstract][Full Text] [Related]
56. The relationship between increases in the hepatic content of cytochrome P-450, form 5, and in the metabolism of aromatic amines to mutagenic products following treatment of rabbits with phenobarbital. Robertson IG; Serabjit-Singh C; Croft JE; Philpot RM Mol Pharmacol; 1983 Jul; 24(1):156-62. PubMed ID: 6865923 [TBL] [Abstract][Full Text] [Related]
57. Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Escherichia coli and by human liver microsomes. Yamazaki H; Inui Y; Wrighton SA; Guengerich FP; Shimada T Carcinogenesis; 1995 Sep; 16(9):2167-70. PubMed ID: 7554070 [TBL] [Abstract][Full Text] [Related]
58. Prosubstrates of CYP3A4, the major human hepatic cytochrome P450: transformation into substrates by other P450 isoforms. Stresser DM; Kupfer D Biochem Pharmacol; 1998 Jun; 55(11):1861-71. PubMed ID: 9714305 [TBL] [Abstract][Full Text] [Related]
59. Retroviral transfer of human cytochrome P450 genes for oxazaphosphorine-based cancer gene therapy. Jounaidi Y; Hecht JE; Waxman DJ Cancer Res; 1998 Oct; 58(19):4391-401. PubMed ID: 9766669 [TBL] [Abstract][Full Text] [Related]
60. Metabolic activation of 4-ipomeanol by complementary DNA-expressed human cytochromes P-450: evidence for species-specific metabolism. Czerwinski M; McLemore TL; Philpot RM; Nhamburo PT; Korzekwa K; Gelboin HV; Gonzalez FJ Cancer Res; 1991 Sep; 51(17):4636-8. PubMed ID: 1651809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]